Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

Impressive clinical benefit is seen in clinic with PD‐1 inhibitors on portion of cancer patients. Yet, there remains an urgent need to develop effective synergizers to expand their clinical application. Tumor‐associated macrophage (TAM), a type of M2‐polarized macrophage, eliminates or suppresses T‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Liang, Jinxia, Yang, Tong, Liu, Jin, Li, Bo, Li, Yingchang, Fan, Zhenzhen, Wang, Weida, Chen, Wensheng, Yuan, Sujing, Xu, Meng, Xu, Qigui, Luan, Zhidong, Xia, Zhongjun, Zhou, Penghui, Huang, Yadong, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749493/
https://www.ncbi.nlm.nih.gov/pubmed/34898004
http://dx.doi.org/10.15252/emmm.202114502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749493/
https://www.ncbi.nlm.nih.gov/pubmed/34898004
http://dx.doi.org/10.15252/emmm.202114502

Ejemplares similares